You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TKI

Showing 26 - 50 of 1,196
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HRQOL in Locally Advanced Thyroid Carcinoma

Recruiting
  • Thyroid Cancer
  • +2 more
  • Tyrosine kinase inhibitor drugs.
  • Fuzhou, Fujian, China
    Road Fuma No.420
Apr 11, 2023

Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • dovitinib lactate
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022

Colorectal Tumors Malignant Trial in Beijing (Fecal microbiota transplantation plus Sintilimab and Fruquintinib)

Recruiting
  • Colorectal Neoplasms Malignant
  • Fecal microbiota transplantation plus Sintilimab and Fruquintinib
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
Aug 21, 2022

NSCLC Trial in Seoul (BBT-176, Cetuximab)

Recruiting
  • NSCLC
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Jan 6, 2023

NSCLC Trial in Shanghai (IN10018, Furmonertinib)

Recruiting
  • NSCLC
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 8, 2023

The Life After Stopping Tyrosine Kinase Inhibitors Study

Completed
  • Leukemia, Myeloid, Chronic
  • Imatinib (Stopping their TKI)
  • +3 more
  • San Francisco, California
  • +15 more
Jan 3, 2023

EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC

Recruiting
  • Non-small Cell Lung Cancer
    • Changsha, Hunan, China
      Yongchang Zhang
    Feb 28, 2022

    Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic Trial in Guangzhou (Chidamide, Dasatinib)

    Recruiting
    • Leukemia
    • +3 more
    • Guangzhou, Guangdong, China
      Department of Hematology, Nanfang Hospital
    Jun 28, 2022

    Non-Squamous NSCLC Trial in Shanghai (Sintilimab, IBI305, Pemetrexed)

    Recruiting
    • Non-Squamous Non-Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Sep 22, 2022

    PD-1 Antibody Plus Chemotherapy for TKI Failure Driver Gene

    Recruiting
    • Non Small Cell Lung Cancer
      • Changsha, Hunan, China
        Yongchang Zhang
      Mar 9, 2022

      Carcinoma, Non-Small Cell Lung, EGFR Gene Mutation Trial in Changsha (Gemcitabine platinum combined with erlotinib)

      Recruiting
      • Carcinoma, Non-Small Cell Lung
      • EGFR Gene Mutation
      • Gemcitabine platinum combined with erlotinib
      • Changsha, Hunan, China
        Hunan Province Tumor Hospital
      Feb 28, 2022

      Advanced Lung Adenocarcinoma Trial (TCM Formula, Placebo)

      Completed
      • Advanced Lung Adenocarcinoma
      • TCM Formula
      • Placebo
      • (no location specified)
      Jan 9, 2022

      Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

      Recruiting
      • Bronchial Neoplasms
      • Cologne, Germany
      • +6 more
      Nov 2, 2022

      MSS, pMMR, Metastatic Colorectal Adenocarcinoma Trial in Shenyang (TKI ± anti-PD-1 antibody)

      Recruiting
      • MSS
      • +2 more
      • TKI ± anti-PD-1 antibody
      • Shenyang, Liaoning, China
        Cancer Hospital of China Medical University/Liaoning Cancer Hosp
      Sep 28, 2021

      Cancer, Cancer, Treatment-Related, Medication Adherence Trial in Chicago (Oncotool Intervention (symptom reporting + TKI

      Completed
      • Cancer
      • +4 more
      • Oncotool Intervention (symptom reporting + TKI education)
      • Oncotool Control (health information)
      • Chicago, Illinois
        Northwestern University
      Jan 25, 2023

      Neovascular Age-Related Macular Degeneration Trial in United States (OTX-TKI/Sham, Aflibercept/Sham)

      Active, not recruiting
      • Neovascular Age-Related Macular Degeneration
      • Bakersfield, California
      • +5 more
      Feb 4, 2022

      GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

      Recruiting
      • Gastro-intestinal Stromal Tumor
      • Vena puncture for blood collection
      • Tumor biopsy
      • Amsterdam, Netherlands
      • +4 more
      May 17, 2022

      Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

      Recruiting
      • Folate
      • +2 more
        • Nantong, China
          Affliated Hospital of Nantong University
        Dec 13, 2021

        Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

        Recruiting
        • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Chronic Phase Chronic Myelogenous Leukemia
        • Text Message-Based Navigation Intervention
        • Survey Administration
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Apr 7, 2022

        Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)

        Recruiting
        • Brain Metastases
        • Non-small Cell Lung Cancer
        • EGFR-TK Inhibitor
        • Stereotactic radiotherapy
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Aug 27, 2023

        Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

        Not yet recruiting
        • Diabetic Macular Edema
        • (no location specified)
        Oct 19, 2023

        NSCLC Trial (PM8002, Placebo, Carboplatin)

        Not yet recruiting
        • NSCLC
        • (no location specified)
        Feb 23, 2023

        FIT to Grow Old - Functionality of Immune System and Healthy

        Active, not recruiting
        • Aging
          • Wageningen, Gelderland, Netherlands
            Department of Human Nutrition & Health, Wageningen University
          Jul 6, 2023